Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Cancer treatments often cause skin, nail, and hair problems.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

About half of Taiwanese dermatologists use dermoscopy, mainly to improve diagnosis and detect cancer early, but cost and lack of training limit its wider use.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Larger nail cavity sizes suggest benign tumors, while smaller ones may need further biopsy to rule out cancer.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Cancer survivors need better skin care to improve their quality of life.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Serums effectively improve skin and hair issues, boosting confidence when used correctly.

A 10-year-old boy's nail condition is mainly cosmetic and improves over time with treatment.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.